noom with glp 1 Med Noom launches Proactive Health GLP-1
Description
The weight loss platform Noom recently launched its compounded GLP-1 microdose injections that claim to promote weight loss with fewer side effects
Amylin is co-secreted with insulin at a ratio of 100:1, that is for every 100 molecules of insulin, 1 molecule of amylin is secreted
Further research into the optimal management of GLP-1 agonists in the perioperative period is therefore needed
GLP1 receptors are also expressed on MCR 4 receptor+ neurons in the paraventricular hypothalamic nucleus (Li, Navarrete, et al., 2019)
This has implications for inventory management, staffing, and dispensing timelines
